Equity Brief · Consumer Defensive2026-05-20
RKT.L·Consumer Defensive

Reckitt Benckiser Group PLC Ord

I · AI Analysis

The brief

Reckitt manufactures and sells consumer products in three core segments: germ protection and disinfectants (Dettol, Lysol, Finish), health and personal care (Nurofen, Gaviscon, Mucinex, Durex, Clearasil), and infant nutrition (Enfamil, Nutramigen) [Company Overview]. The company sells globally through retail chains, pharmacies, and e-commerce, serving 36,200 employees across international markets [Company Overview].

Reckitt Benckiser is a UK-based consumer goods giant with a portfolio of household brands including Dettol, Lysol, Finish, Durex, Nurofen, and Enfamil infant formula [Company Overview]. The company generates GBp 14.2B in annual revenue across health, hygiene, and nutrition categories, with a market cap of GBp 30.1B [Yahoo Finance]. Financial health is solid with strong margins and manageable debt, though revenue growth has stalled at just +0.3% year-over-year [Yahoo Finance].

Strong profitability and cash generation with manageable leverage, but revenue growth has flatlined.

The brief AI analysisConfidence 6/10

Sentinellis health

7.4/10

Moderate concerns

Market capitalisation

GBP 30.1B

Revenue (TTM)

GBP 14.2B

Explainers

How we read these numbers

Plain-English guides · no account needed

Premium · Free with any account

Revenue growth has stalled at +0.3% year-over-year, suggesting the company is struggling to expand in mature categories or facing competitive pressure from private-label brands [Yahoo Finance].

1 of 5 risks in this report

Risks

5

Opportunities

5

Red flags

3

Leadership

10

12 more findings in the full report — free with any account.

Unlock the full Reckitt Benckiser Group PLC Ord analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 5 risks, 5 opportunities and 3 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Unlock all 13 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Consumer Defensive — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 20 May 2026, 19:55 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated